BioSyent Releases Q2 and H1 2021 Financial Results
25. August 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and six months ended June 30, 2021. Key...
BioSyent Schedules Q2 and H1 2021 Earnings Release for August 25, 2021
17. August 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
BioSyent Signs Exclusive Technology Agreement
13. Juli 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, July 13, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an agreement to...
BioSyent Releases Financial Results for Q1 2021
27. Mai 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2021. Key highlights...
BioSyent Schedules Q1 2021 Earnings Release for May 27, 2021
20. Mai 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 20, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2021 on...
FeraMAX(MD) est le 1er choix de supplément de fer recommandé par les pharmaciens et les médecins canadiens pour la sixième année consécutive
05. Mai 2021 08:42 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, 05 mai 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », Bourse de croissance TSX : RX) a le plaisir d’annoncer que pour la sixième année consécutive, FeraMAXMD a été...
FeraMAX® Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year
03. Mai 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 03, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the sixth consecutive year, FeraMAX® has been named the #1...
BioSyent to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference
14. April 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co....
BioSyent Announces Grant of Restricted Share Units
19. März 2021 17:33 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 67,252 Restricted...
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2020
17. März 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and twelve months ended December 31, 2020. Key...